Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Sort By: Relevancy | Date | Type
Displaying items 25-36 of 606
» View wsbt.com items only
    Jun 10, 2013 |Story| South Bend Tribune
  1. New home, same focus

    SOUTH BEND -- The Northern Indiana Affiliate of the Susan G. Komen Foundation hopes the annual Race for the Cure has found a permanent home at Potawatomi Park.
    South Bend Tribune
    SOUTH BEND -- The Northern Indiana Affiliate of the Susan G. Komen Foundation hopes the annual Race for the Cure has found a permanent home at Potawatomi Park. After years of snow, rain and sleet, the organizers think moving the event, which raises money...

    Tags: Breast Cancer, Susan G. Komen for the Cure, Planned Parenthood, Event Planning, Services and Shopping

  2. Jun 10, 2013 |Story| South Florida Sun-Sentinel
  3. Angelina Jolie made right choice

    I was truly horrified to read the "Dear Pharmacist" column, "Why I disagree with Angelina Jolie's mastectomy decision." Suzy Cohen may be a pharmacist, but she is not a medical or surgical oncologist, nor is she a certified genetics counselor. Therefore,...

    Tags: Breast Cancer, Health Treatments, Angelina Jolie, Chemotherapy, Health and Medical Professionals

  4. Jun 12, 2013 |Story| Orlando Sentinel
  5. New service matches patients with clinical-research trials in Orlando

    In Orlando, more than 550 clinical trials are looking for participants to help find better treatments and cures for such chronic diseases as cancer, AIDS and diabetes. Across Florida, nearly 2,500 studies are looking for subjects.
    In Orlando, more than 550 clinical trials are looking for participants to help find better treatments and cures for such chronic diseases as cancer, AIDS and diabetes. Across Florida, nearly 2,500 studies are looking for subjects. "We have a lot of...

    Tags: Trials, Diseases and Illnesses, Medical Research, Marketing, Leukemia

  6. Jun 3, 2013 |Story| Reuters
  7. Clovis shares double on positive early data for lung cancer drug

    Reuters
    June 3 (Reuters) - Clovis Oncology said initial results of an early-stage trial of its experimental lung cancer drug showed a reduction in tumor size, prompting investors to more than double the company's market value on Monday. The experimental therapy,...

    Tags: Diseases and Illnesses, Ovarian Cancer, Lung Cancer

  8. Jun 3, 2013 |Story| Reuters
  9. Synta drug shown to extend lives of certain lung cancer patients

    Reuters
    CHICAGO, June 3 (Reuters) - A drug designed to block a protein known to help cancer cells grow was shown in a mid-stage trial to lengthen survival in patients with advanced lung cancer that worsened after initial treatment, researchers said on Monday....

    Tags: Health Treatments, Trials, Biotechnology, Medical Research, Science and Technology

  10. Jun 3, 2013 |Story| Reuters
  11. Roche's Avastin extends life in advanced cervical cancer

    Reuters
    By Bill Berkrot June 3 (Reuters) - Roche Holding AG's drug Avastin helped prolong the lives of women with advanced cervical cancer when added to chemotherapy in a late-stage clinical trial, likely paving the way to another major use for the multibillion-...

    Tags: Breast Cancer, Roche Holding AG, Bevacizumab (drug), Trials, Health Treatments

  12. Jun 3, 2013 |Story| Reuters
  13. Longer tamoxifen use reduces breast cancer recurrence

    Reuters
    By Deena Beasley CHICAGO, June 3 (Reuters) - Breast cancer is less likely to recur if women previously treated for the disease take the drug tamoxifen for 10 years, instead of the recommended five years, according to a British study. The study was a...

    Tags: Science and Technology, Medical Research, Tamoxifen (drug), New York University, Chemotherapy

  14. Jun 3, 2013 |Story| Reuters
  15. BioMarin's cancer drug success prompts launch of pivotal trial

    Reuters
    June 3 (Reuters) - An experimental cancer drug from BioMarin Pharmaceutical Inc has proven to be effective in treating patients with breast or ovarian cancers caused by mutation in the BRCA gene that repairs damaged DNA, early data show. The drug,...

    Tags: Biotechnology Industry, Breast Cancer, Chemical Industry, Ovarian Cancer, Science and Technology

  16. Jun 2, 2013 |Story| Reuters
  17. Bayer's Nexavar shown to delay thyroid cancer by 5 months

    Reuters
    FRANKFURT, June 2 (Reuters) - Bayer said on Sunday its cancer drug Nexavar was shown to delay progression of a difficult-to-treat type of thyroid cancer by about five months, as the German drugmaker seeks to widen the use of the pill. The indication,...

    Tags: Litigation, Breast Cancer, Trials, Prescription Drugs, Placebo

  18. Jun 2, 2013 |Story| Reuters
  19. Roche's Avastin fails to prolong survival in brain cancer study

    Reuters
    By Bill Berkrot June 2 (Reuters) - The widely used Roche Holding AG cancer drug Avastin failed to prolong survival when added to chemo-radiation therapy for glioblastoma - a fast-growing type of brain tumor - according to data presented on Sunday....

    Tags: Medical Research, Science and Technology, Chemotherapy, Bevacizumab (drug), Breast Cancer

  20. May 29, 2013 |Story| Orlando Sentinel
  21. Examining which cancer screenings you may not need

    Early detection of cancer is the best chance of cure, right? Maybe not.
    Early detection of cancer is the best chance of cure, right? Maybe not. A growing body of counterintuitive evidence suggests that some cancer-screening tests — including those for breast, prostate, colon, lung and cervical cancer — may be...

    Tags: Medical Research, General Practitioners, Colonoscopy, Mammogram, Diseases and Illnesses

  22. May 30, 2013 |Story| Baltimore Sun
  23. Glaxo anti-cancer cocktail gets regulatory approval

    <span>After her melanoma, Cheryl Stratos is mostly back to a normal life, running a business and driving her teenage son to weekend events, but there are reminders that it could all come back: The sores all over her body, the high fevers, the hair loss -- even the possibility of a suddenly shortened life. For Stratos, of Virginia, and others who have benefitted from a class of revolutionary anti-cancer drugs known as BRAF mutation inhibitors, another tool in the fight against relapse has just been sharpened: Drug maker GlaxoSmithKline received FDA </span><a href="http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm354199.htm"><span>approval</span></a><span> Wednesday for a new cocktail that includes a BRAF-targeting component. </span>
    The Baltimore Sun
    After her melanoma, Cheryl Stratos is mostly back to a normal life, running a business and driving her teenage son to weekend events, but there are reminders that it could all come back: The sores all over her body, the high fevers, the hair loss --...

    Tags: Rockville (Bethlehem, Pennsylvania), Health Organizations, GlaxoSmithKline PLC, Human Genome Sciences Inc., American Cancer Society

< Previous1 2  3  4 5 6 7 8 9 10 11-51Next >
Original site for Oncology topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Oncology Photos
Anaiss Cardenas (left), medical assistant with El Centr...
(June 7, 2013)
Dr. Ijaz I. Arshad, medical director of the Cancer Inst...
(May 15, 2013)
Dr. Ijaz I. Arshad
Colleen Kisel of the Pediatric Oncology Treasure Chest...
(April 26, 2013)
Colleen Kisel of the Pediatric Oncology Treasure Chest Foundation